Cases & Deals

Share

Bay City Capital fund invests in DxCon

June 2009

Client(s) Bay City Capital Fund V

Jones Day advised Bay City Capital Fund V in connection with its purchase of $4.7 million of Series A Convertible Preferred Stock in a private placement by DxCon, Inc., a pharmaceutical company.

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.